Siblings 會議論文/會議摘要 [1/1] 專利 [0/1] Collection Statistics 近3年內發表的文件:0(0.00%) 含全文筆數:29(100.00%) 文件下載次數統計 下載大於0次:29(100.00%) 下載大於100次:29(100.00%) 檔案下載總次數:27707(97.09%) 最後更新時間: 2024-11-28 19:06 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Doubly spliced RNA of hepatitis B V... Doxorubicin activates hepatitis B v... The inhibitory effect of the hepati... Copy number change of the NDM-1 seq... ALPK1 genetic regulation and risk i... One single nucleotide difference al... Transforming growth factor-beta1 su... HNF-4alpha determines hepatic diffe... Decreased expression of UK114 is re... Prevention of TGF-beta-induced apop...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 29. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2015-11	Doubly spliced RNA of hepatitis B Virus suppresses viral transcription via TATA-binding protein and induces stress granule assembly	Journal of Virology. 2015 Nov;89(22):11406-11419.
2015-06-29	Doxorubicin activates hepatitis B virus replication by elevation of p21 (Waf1/Cip1) and C/EBPalpha expression	PLoS ONE. 2015 Jun 29;10(6):Article number e0131743.
2015-03-18	The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation	PLoS ONE. 2015 Mar 18;10(3):Article number e0119625.
2013-06	One single nucleotide difference alters the differential expression of spliced RNAs between HBV genotypes A and D	Virus Research. 2013 Jun;174(1-2):18-26.
2013-04-29	Copy number change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate	PLoS ONE. 2013 Apr 29;8(4):Article number e62774.
2013-04	ALPK1 genetic regulation and risk in relation to gout	International Journal of Epidemiology. 2013 Apr;42(2):466-474.
2012-01	Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression	PLoS ONE. 2012 Jan;7(1):Article number e30360.
2010-10-28	HNF-4alpha determines hepatic differentiation of human mesenchymal stem cells from bone marrow	World Journal of Gastroenterology. 2010 Oct 28;16(40):5092-5103.
2010-02	Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91	Pharmacological Research. 2010 Feb;61(2):108-115.
2009-04-20	HBV replication is significantly reduced by IL-6	Journal of Biomedical Science. 2009 Apr 20;16:Article number 41.
2008-10	Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma [Erratum: Cancer Epidemiology Biomarkers & Prevention. 2008 Oct;17(10):2901-2901.]	Cancer Epidemiology Biomarkers & Prevention. 2008 Oct;17(10):2901.
2008-03	Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma	Cancer Epidemiology Biomarkers and Prevention. 2008 Mar;17(3):535-542.
2007-09	Transforming growth factor-beta suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA	Hepatology. 2007 Sep;46(3):672-681.
2007-09	Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways	Apoptosis. 2007 Sep;12(9):1659-1670.
2006-05	Clonal restriction of the expansion of antigen-specific CD8(+) memory T cells by transforming growth factor-beta	Journal of Leukocyte Biology. 2006 May;79(5):1033-1042.
2005-02	Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcriptiori-PCR combined with the restriction enzyme digestion method	Journal of Virology. 2005 Feb;79(3):1813-1823.
2005	Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta 1 and interleukin-6 in the development of in situ tumor immunity	Immunobiology. 2005;210(9):661-671.
2004-03-08	Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives	Bioorganic and Medicinal Chemistry Letters. 2004 Mar;14(5):1169-1172.
2003-11-01	IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B	Journal of Immunology. 2003 Nov;171(9):4708-4716.
2003-10-30	Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways	Oncogene. 2003 Oct;22(49):7809-7818.
2002-06-06	Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents	Journal of Medicinal Chemistry. 2002 Jun;45(12):2556-2562.
2002-04-11	Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors	Journal of Medicinal Chemistry. 2002 Apr;45(8):1644-1655.
2001-11	Hepatitis B viral polymerase fusion proteins are biologically active and can interact with the hepatitis C virus core protein in vivo	Journal of Biomedical Science. 2001 Nov;8(6):492-503.
2000-10	Effects of genomic length on translocation of hepatitis B virus polymerase-linked oligomer	Journal of Virology. 2000 Oct;74(19):9010-9018.
2000-09-30	Identification and characterization of a structural protein of hepatitis B virus: A polymerase and surface fusion protein encoded by a spliced RNA	Virology. 2000 Sep;275(2):398-410.

顯示項目1-25 / 29. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目